Personalizing Chemotherapy for Black Women - Susan G. Komen®
Komen Scholar Bryan Schneider, M.D., trial lead for the EAZ171 clinical trial, is seeking to overcome these disparities in outcomes for Black women with breast cancer by personalizing chemotherapy.| Susan G. Komen®
